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O R I G I N A L  A R T I C L E
We examined antioxidant actions in 73 patients under-
going coronary artery surgery by assessing mitochondri-
al damage and oxidative stress in ventricular biopsies
obtained at preischemia and postreperfusion. Those
patients who received antioxidant therapy benefited by
less oxidative stress and mitochondrial damage.
JOSÉ MILEI, MD, PhD
Cardiopsis; Facultad de Medicina
de la Universidad del Salvador
Laboratorio de Radicales Libres en
Biología y Medicina





DANIEL R. GRANA, VMD
Cardiopsis; Facultad de Medicina
de la Universidad del Salvador
Buenos Aires, Argentina
ALBERTO BOVERIS, PhD
Laboratorio de Radicales Libres en
Biología y Medicina











Dr José Milei, Tucumán 2163, (C1050AAQ) Buenos Aires, ARGENTINA 
ACKNOWLEDGMENTS
This study received partial support from the Consejo Nacional de Investiga-
ciones Científicas y Técnicas (Argentina) and the Universidad de Buenos Aires,
Argentina.
Submitted for publication: March 17, 2000. Accepted: May 16, 2000.
I N T R O D U C T I O N
Heart reperfusion injury is a complex phenomenon
leading to biochemical and ultrastructural changes
in myocardial cells which in turn may lead to elec-
trical and hemodynamic cardiac dysfunctions,
which are expressed as myocardial stunning and
reperfusion arrhythmias.1,2
Almost ten years ago, a study from our group pro-
vided the first evidence of oxidative stress associat-
ed with ultrastructural damage in the human heart
during reperfusion and suggested the involvement
of oxygen free radicals.2 That study compared
oxidative stress, assayed as hydroperoxide-initiated
chemiluminescence, with mitochondrial damage,
determined by electron microscopy, in pairs of
biopsies obtained before ischemia and after reperfu-
sion. The study concluded that “the presence of
oxidative stress during reoxygenation…may play a
major role in the genesis of reperfusion injury”.2
Previous work in experimental models, had shown
that a variety of antioxidants and scavengers can
ameliorate the histological changes and functional
disturbances produced by the ischemia-reperfusion
in the heart.3-5 These results suggested that better
heart protection could be achieved with the addition
of antioxidants or related substances to the cardio-
plegic solution. In our experience, supplementation
of the cardioplegic solution with mannitol6 or defer-
oxamine,7 or the preoperative intravenous infusion
of taurine8 reduced tissue damage and oxidative
stress. In addition, the preoperative administration of
vitamins A and E significantly decreased heart oxida-
tive stress.9 We also observed that blood cardioplegia
supplemented with mannitol showed better results
than plain crystalloid cardioplegic solutions in
patients with normal ventricular mass.10
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Numerous studies, including our own, have
demonstrated oxidative stress during coronary revas-
cularization. However, some derived subjects need
to be addressed. 1) The occurrence of irreversible
mitochondrial damage; 2) the existence of oxidative
stress secondary to oxygen free radical overproduc-
tion; 3) the beneficial effect of antioxidants; and 4)
the degree of myocardial protection afforded by
these drugs. We present a review of our experience
in this field aimed at defining the effective antioxi-
dant actions for coronary artery surgery.2,6-10
M A T E R I A L  A N D  M E T H O D S
All the data from previous studies2,6-10 were grouped
and analyzed. The data consist of a control
ischemia reperfusion group and treatment groups
(mannitol, deferoxamine, taurine, vitamins A and
E, and blood.6-10
Patients. Seventy patients who underwent coro-
nary artery surgery were studied.6-10 In order to
obtain a homogeneous group, the patients selected
for the studies fulfilled the following criteria: 1)
ejection fraction greater than 45%; 2) absence of
recent (less than 4 weeks) myocardial infarction; 3)
absence of associated valve disease; and 4) achieve-
ment of a complete or satisfactory surgical revascu-
larization. Written informed consent for
participation in the study was obtained from each
patient and the institutional review board approved
the study protocol.
Cardiopulmonary bypass was instituted and the
temperature of the perfusate was lowered to 28° C.
Topical hypothermia with crushed-iced saline solu-
tion was applied. Before the aorta was cross-
clamped, two full-thickness biopsies were obtained
from the apex of the heart, and were designated as
preischemia or basal samples. The biopsy sample
for chemiluminescence assay was immersed in
saline solution and frozen. The second biopsy sam-
ple, for electron microscopy, was immersed in cold
3% glutaraldehyde in 0.1 mol/L phosphate buffer
(pH 7.4).
After placement of the aortic clamp, 500 mL of
Saint Thomas-type cardioplegic solution, at a tem-
perature of 4° C, was injected at 80–100 mm Hg
into the aortic root. A needle thermistor was insert-
ed into the septum for continuous monitoring of the
myocardial temperature, which ranged from 18° to
22° C. After completion of the distal anastomoses,
the aortic clamp was removed and the heart defib-
rillated. In most instances, countershocks were nec-
essary to return the heart to sinus rhythm (mean
value of applied countershocks = 1.6 ± 0.3). Ten
minutes after reperfusion and with the patient
rewarmed, two new biopsies were obtained, desig-
nated as reperfusion samples and processed in a
similar manner.
The main clinical and surgical characteristics of
the patients in the study groups are shown in Table
1. There was no significant difference in age, ejec-
tion fraction, aortic cross-clamp time, and number
of grafts among groups.
Antioxidant Treatments.
• Mannitol group (n=6): the cardioplegic solution
contained 59.8 mmol mannitol (Laboratory
FADA, Buenos Aires, Argentina).6
• Deferoxamine group (n=7): the cardioplegic
solution was supplemented with 1 g/L of defer-
oxamine (Ciba-Geigy, Buenos Aires,
Argentina).7
• Taurine group (n=6): 1–3 hours before surgery,
patients received a rapid intravenous infusion
of 5 g of taurine (O-due, Istituto Farmacochimi-
co Nativelle, Florence, Italy).8
• Vitamins A and E group (n=8): patients
received an oral administration of 400 mg of
vitamin E and 100,000 IU of vitamin A daily
for five days before surgery.9
• Blood group (n=10): myocardial protection was
achieved using blood cardioplegia supplemented
with 40 mmol/L mannitol and 20 mmol/L KCl.10
Heart Oxidative Stress. Oxidative stress was
indirectly studied using the hydroperoxide-initiated
chemiluminescence assay.11,12 Biopsy samples
(approximately 20 mg) were homogenized in 2 mL
of 140 mmol KCl and 20 mmol phosphate buffer
(pH 7.3). The protein homogenate was adjusted to 1
mg/mL and 3 mmol of tert-butyl hydroperoxide was
added to the suspension, and was immediately
assayed for chemiluminescence in a scintillation
counter in the out-of-coincidence mode for single
photon counting. Chemiluminescence was
expressed as counts/minute per milligram of protein
of the homogenate.
The oxidative stress index was calculated dividing
the chemiluminescence yield after reperfusion by
the chemiluminescence yield before reperfusion.
This adimensional number expresses induced oxida-
tive stress by any number higher than one.12
Mitochondrial Damage. The biopsy tissues
used for transmission electron microscopy were
fixed in cold 3% glutaraldehyde in 0.1 mol/L
cacodylate buffer (pH 7.4), postfixed in 1% osmium
tetroxide, dehydrated and embedded in Epon. Three
blocks were selected from different depths of each
biopsy sample. From each block, a 1 µm section
was cut, stained with 1% toluidine-borax, and
examined by light microscopy to select appropriate
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areas for thin sectioning. Five ultrathin sections
were obtained from each of the three blocks. Ultra-
thin sections were mounted in copper grids, stained
with uranyl acetate and lead citrate, and examined
in an electron microscope.
Electron micrographs were taken systematically
at magnifications of 5000× and mitochondrial dam-
age was determined in a blind manner by two dif-
ferent observers who assigned a single score to each
of the areas using criteria based on Kloner et al.13 A
numerical value of 0 through 4 was assigned for
each mitochondrion, depending on the degree of
morphologic damage. The grading scale was as fol-
lows: 0—normal mitochondria; 1—early swelling as
manifested by separation of cristae and clearing of
matrix density; 2—more marked swelling than in
grade 1; 3—massive swelling with architectural dis-
ruption; and 4—the same as 3 with rupture of inner
and outer mitochondrial membranes. The average
obtained from the two observers was expressed for
each grade (0 to 4) as a percentage of the total num-
ber of mitochondria counted per sample. Approxi-
mately 500 mitochondria per biopsy were graded in
this manner. Mitochondria graded 3 and 4 were
considered irreversibly damaged.13 The mitochondr-
ial damage index induced by reperfusion was calcu-
lated by dividing the percentage of irreversibly
damaged mitochondria (grades 3 and 4) after reper-
fusion by the same percentage before reperfusion.
This adimensional number expressed induced dam-
age by any number higher than one.
Statistical Analysis. Comparisons between
groups were done with an analysis of variance with
post-hoc tests (Dunnett). Values in tables are pre-
sented as mean values ± SEM, with an assigned
significance level of .05.
R E S U L T S
Clinical Outcome. The patients had a satisfactory
postoperative outcome. No evidence of periopera-
tive myocardial infarction was observed by the
appearance of new Q waves in the electrocardio-
gram (ECG) or by increased values for serum crea-
tine phosphokinase. Four patients in the control
group and 3 in the mannitol group required inotrop-
ic support 4–18 h postopertively. One patient in the
control group had uncontrolled gastrointestinal
bleeding and died on the 13th postoperative day.
Two patients in the deferoxamine group required
electrical conversions of atrial fibrillation within the
first 12 postoperative hours.
Oxidative Stress. The oxidative stress index
value of 2.13 in the control group clearly indicates
the occurrence of oxidative stress12 during the reper-
fusion of the heart undergoing coronary revascular-
ization (Table 2). The index value of 2.13 implies a
113% increase in hydroperoxide-initiated chemilu-
minescence, which corresponds to a decreased con-
tent of vitamin E and other related antioxidants in
the biopsy. This decreased content of endogenous
antioxidants indicates a previously increased rate of
oxygen free radical reactions.12 The oxidative stress
indexes for the various treatments indicate protec-
tion values of 44 and 94% for the supplementation
of the cardioplegic solution with deferoxamine and
mannitol, respectively, a protection value of 84% for
taurine infusion, and of 100% for pretreatment with
vitamin A and E. As the basal samples of the treat-
ment and control groups were not significantly dif-
ferent (± 15%), the lower oxidative stress indices in
all the treatment groups were due to significant
decreased hydroperoxide-initiated chemilumines-
cence in the postreperfusion samples. (Figure 1)
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Tissue Injury and Mitochondrial Damage.
General description. Basal samples in all the groups
showed normal sarcomere structure with normal
mitochondrial arrangement and tightly packed
cristae and gray matrix density. The morphologic
changes in the postreperfusion biopsy specimens of
the control group, consisted of focal myofibrillar
disorganization with myocytolisis, sarcoplasmic vac-
uolization, and mitochondrial swelling and disrup-
tion. Distension of sarcoplasmic reticulum and T
tubules were frequently seen and diffusely scat-
tered in damaged myocytes. Mitochondria showing
swelling, clearing of matrix density, and separation
of cristae with granular and linear densities or mye-
line figures and membrane disruption were
observed in the most advanced stages.
Mitochondrial damage. The morphologic quantita-
tive analysis of the biopsy specimens showed that
the occurrence of mitochondria graded 0, 1 and 2
were not statistically different between groups. The
number of severely damaged mitochondria, graded 3
and 4, increased markedly from 10.2% to 26.8% fol-
lowing reperfusion in the control group, resulting in
a mitochondrial damage index of 2.63. Supplementa-


























Oxidative stress indexes were determined as the ratio of hydroperoxide-initiated chemiluminescence after
reperfusion/before reperfusion in the biopsies obtained from each patient. All treatments, except deferox-
amine, were statistically (P < .01) different from the control ischemia-reperfusion condition. Deferoxam-
ine treatment has a difference with P = .05. The mean value for hydroperoxide-initiated
chemiluminescence in all the biopsies (control and treatments) was 32.7 x 103 cpm/mg of protein.
Figure 1.—Hydroperoxide-initiated chemiluminescence in heart biopsies of patients subjected to coronoary revascularization surgery. Ctrol,
basal sample; I-R, reperfusion sample without treatment; Man, reperfusion sample of mannitol treatment; Def, reperfusion sample of deferox-
amine treatment; Vit, reperfusion sample of vitamins A and E treatment; Tau, reperfusion sample of taurine treatment.
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tion of the cardioplegic solution with mannitol or
deferoxamine produced protection values of 63%
and 47%, respectively, and taurine infusion or the
use of mannitol in blood cardioplegia provided pro-
tection values of 85 and 95%, respectively. (Figures
2–5) Regarding mitochondrial damage, statistical dif-
ferences were observed in the percentages of injured
mitochondria between the postreperfusion control
samples and the basal samples of the control group
and the postreperfusion samples of all the treated
groups. Furthermore, significant differences were
observed between the postreperfusion samples of
untreated and treated patients. (Figure 6 & Table 3)
D I S C U S S I O N
In the 1970s, Hearse created the concept of “the
oxygen paradox”,14 and thereafter, its pathophysiol-
ogy has been extensively researched. Hearse
described that after a period of ischemia, ultrastruc-
tural damage to the heart increases during reperfu-
sion. This is associated with functional alterations
of the myocardial contractility and arrhythmias, and
is a major concern during surgical procedures
requiring cardiopulmonary bypass.1 Thus, various
substances have been evaluated to lessen myocar-
dial damage during ischemia-reperfusion.
In our experience the use of mannitol,6 deferox-
amine,7 taurine,8 vitamins A and E,9 and blood car-
dioplegia supplemented with mannitol10 seemed to
ameliorate reperfusion damage by decreasing
oxidative stress and mitochondrial damage. Experi-
mental studies in rabbits15-18 also demonstrate the
overproduction of oxygen free radical and the
occurrence of oxidative stress in coronary artery
Figure 2.—Mitochondria show tightly packed cristae and intact
membranes. Basal sample specimen, only some of them present
mild swelling. Transmission electron micrograph 10,000×.
Figure 3.—Basal sample from a specimen of the mannitol group.
In general, mitochondria are well preserved as in figure 2 10,000×.
Figure 4.— Reperfusion sample protected with mannitol. Mito-
chondrial structures are preserved and only mild and moderate
swelling can be observed.
Figure 5.—Reperfusion sample specimen showing severe mito-
chondrial damage with massive swelling and disruption of cristae,
rupture of membranes and deposits of amorphous bodies. Trans-
mission electron micrograph 10,000×.
COMP THER. 2001;27(2) 113
surgery and other clinical situations in which
ischemia-reperfusion takes place.
In the present study, we grouped the data of vari-
ous clinical trials6-10 to compare the degrees of myocar-
dial protection afforded by the different treatments.
The indices of oxidative stress, taken from the
hydroperoxide-initiated chemiluminescence of the
biopsies, and of mitochondrial damage, determined
by counting damaged mitochondria in the electron
micrographs taken for the different treatments
showed a statistical correlation (r = 0.95 ; P <
.001). (Figure 7) A similar correlation between
oxidative stress and mitochondrial damage was pre-
viously reported in individual heart biopsies.12
The mechanism by which oxygen free radicals are
generated during reperfusion19 is still debated. The
role of xanthine oxidase as a source of oxygen free
radicals has been reported in animals. However, lit-
tle if any xanthine oxidase activity occurs in the
human heart.8 Alternately, it has been suggested that
injured endothelial cells from damaged vessels could
be a source of oxygen free radicals in the heart.20


























Mitochondrial damage indexes were determined as the ratio of the percentage of irreversibly damaged
mitochondria after reperfusion/before reperfusion in the biopsies obtained from each patient. All treat-
ments, except deferoxamine, were statistically (P < .01) different from the control ischemia-reperfusion
condition. Deferoxamine treatment was different with a P < .05. The mean value for the percentage of
mitochondria showing grades 3 and 4 damage in all biopsies (control and treatments) was 10.2%.
Figure 6.—Irreversible damaged mitochondria in heart biopsies of patients subjected to coronary revascularization surgery. Ctrol, basal
sample; I-R, reperfusion sample without treatment; Man, reperfusion sample of mannitol treatment; Def, reperfusion sample of deferoxamine
treatment; Tau, reperfusion sample of taurine treatment; Blood: reperfusion sample of blood cardioplegia plus mannitol treatment.
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Another hypothesis suggests that during reperfu-
sion, oxygen encounters a highly reduced mitochon-
drial respiratory chain that triggers an
overproduction of superoxide anion at the inner
mitochondrial membrane.21,22 After dismutation of
the superoxide anion at the mitochondrial matrix,
the resulting hydrogen peroxide diffuses out of the
cytosol, reacts with myoglobin, and produces
hydroxyl radicals that initiates free radical chain
reaction. (Figure 8) The results of each antioxidant
treatment will be addressed separately.
Mannitol. Mannitol has been reported to
improve myocardial function after ischemia.
Bernier et al.4 found a decreased incidence of ven-
tricular fibrillation associated with a reduction of
myocardial edema in the isolated perfused rat
heart when 50 mmol/L mannitol was added to the
cardioplegic solution. In addition, we found that
mannitol also decreased the number of counter-
shocks required to return the heart to sinus
rhythm, reduced rhythm disturbances in the post-
operative period, appreciably reduced oxidative
stress and mitochondrial damage.6 Two mecha-
nisms can explain these effects: 1) an action as a
hydroxyl radical scavenger;6 and 2) an osmotic
effect through the hyperosmotic activity of the
extracellular medium.6
Deferoxamine. Iron is an important catalyst in
the generation of oxygen free radicals through the
Fenton reaction, with formation of hydroxyl radical
leading to lipid peroxidation. For this to occur, suit-
able chelated forms of iron are needed. Deferoxam-
ine diminishes free iron toxic effects by forming a
high-affinity, catalytically inactive, chelate7 that pre-
vents reperfusion injury.23,24
Ambrosio et al.25 reported good recovery of
myocardial function and energy metabolism. How-
ever, in isolated rat hearts, no effects were seen
during preconditioning26 and deferoxamine provid-
ed poor protection in ischemia-reperfusion.27 In iron
loaded rats, deferoxamine prevented the generation
of ventricular fibrillation and normalized contractili-
ty.28 Rat hearts pretreated with deferoxamine
showed better recovery of adenosine triphosphaye
and aortic blood flow.29 In our experience, the addi-
tion of deferoxamine to the cardioplegic solution
significantly reduced oxidative stress and mitochon-
drial damage of the myocardium during reperfusion.7
Vitamins A and E. These natural antioxidants
that scavenge peroxyl radicals generated during the
propagation phase of lipid peroxidation. In addition,
vitamin A effectively quenches singlet oxygen.9 Sev-
eral trials have demonstrated the benefit of vitamin
E for the prevention of coronary heart disease, but
few report its use as an antioxidant in cardiac
surgery. Sisto and coworkers,30 evaluated 40
patients undergoing coronary artery surgery. The
patients were randomized into two groups: 1) place-
bo and 2) 4 weeks pretreatment with vitamin E 600
mg/day plus allopurinol 600 mg for two days before
surgery. The group receiving vitamin E and allop-
urinol required less dopamine perioperatively and
had fewer ECG events.
We observed a marked decrease in the oxidative
stress index in patients receiving vitamins A and E
preoperatively, suggesting that these substances
Figure 7.—Relationship between the indexes of oxidative stress
and of mitochondrial damage in heart biopsies of patients subject-
ed to coronary revascularization surgery with different treatments.
Figure 8.—Scheme of the proposed mechanism for O2– / H2O2
increase associated to ischemia-reperfusion in heart. Statements A
and B represent mitochondrial changes during ischemia (A) and
reperfusion (B). UQ and UQH•, oxidized and reduced forms of
ubiquinone; FMN and FMNH•, oxidized and reduced forms of NADH
dehydrogenase flavoprotein; Mb–O2, myoglobin–O2; Cyt c,
cytochrome C; FeIV = O, perferryl hemoprotein.
COMP THER. 2001;27(2) 115
effectively counter free radical overproduction in
myocardial cells during reperfusion.9
Taurine. Taurine is one of the most abundant
intracellular amino acids in mammalian hearts and
its deficiency is implicated in various pathologic
states of the heart. Aside from its other effects, tau-
rine may have antioxidant and scavenging proper-
ties.8,31,32 The cardioprotective action of taurine,
both in vitro and in vivo, is well documented in the
literature.8 Irrespective of the cardioplegic solution
used, patients undergoing coronary artery surgery,
showed a fall in heart tissue taurine, possibly influ-
encing the extent of recovery following surgery.31
Taurine maintains mechanical heart function
through a calcium concentration dependent bipha-
sic action.8 In the isolated rat heart, taurine pre-
vents both the large decline in ATPase activities and
the associated increase in sarcolemmal calcium
binding.8 In hamsters with cardiomyopathy, oral
pretreatment with taurine decreased the accumula-
tion of calcium and the severity of lesions.8
Taurine has shown beneficial actions in patients
with congestive heart failure,8 possibly through a
modulatory action on calcium entry at the sarcolem-
mal level. Taurine, in our experience, was able to
prevent oxidative stress and mitochondrial damage
showing a definite cardioprotective action during
cardiovascular surgery.8
Blood Cardioplegia Supplemented With Man-
nitol. In 1989, a new concept in myocardial protec-
tion was initiated as an alternative to the standard
use of hypothermia.33 This technique involved con-
tinuous, normothermic blood-potassium perfusion
during the cross-clamp period, which provides an
uninterrupted supply of oxygenated blood to the
myocardium.34 Crystalloid cardioplegic solutions
have at least three major disadvantages compared
with blood cardioplegic solution: 1) It supplies only
small quantities of oxygen to the myocardium; 2) it
significantly hemodilutes the patient; and 3) it
decreases the oncotic pressure.35
Mullen et al.36 compared blood cardioplegia with
crystalloid cardioplegic solutions after coronary
artery operations. Blood cardioplegia provided
excellent protection for the left ventricle, whereas
crystalloid cardioplegic solutions produced colder
right ventricular temperatures and better postopera-
tive right ventricular function. Blood cardioplegia
appears superior to crystalloid solutions and the
benefits of adding mannitol to blood cardioplegia
were observed in patients with normal ventricular
mass in whom an adequate preservation of the
ultrastructure in the reperfusion samples was
achieved.10 In a current study, we are comparing
the myocardial protection afforded by warm blood
to cold crystalloid cardioplegic solution in patients
undergoing elective coronary artery surgery. Signifi-
cant rises in thiobarbituric acid reactive substances
(increase lipid peroxidation) in coronary sinus plas-
ma were found with both crystalloid and blood car-
dioplegia. Increased mitochondrial damage was
found in both groups, but statistical significance
was only observed within both groups between
preischemia and reperfusion. In conclusion, it is
apparent that blood cardioplegia may afford better
protection than crystalloid cardioplegic solutions.
C O N C L U S I O N S
Several alternatives may be taken into consideration
to improve myocardial protection in patients under-
going coronary artery surgery, namely: 1) the
administration of warm blood cardioplegia; 2) the
use of combined anterograde/retrograde cardiople-
gia; 3) the addition of oxygen free radical scav-
engers to the cardioplegic solutions; and 4)
pretreatment of the patients with vitamins A and E.
Although several issues remain unclear, there is no
doubt that oxygen free radicals are important con-
tributors to myocardial injury during the reperfu-
sion period of coronary artery surgery.
From our results, the association of preoperative
oral vitamins A or β-carotene and vitamin E and the
addition of mannitol, deferoxamine and taurine to
cardioplegic solutions seems advisable.
In the meantime, trimetazidine, shown to preserve
energy balance and reduce intracellular acidosis and
free radical induced injury,37 and normothermic
blood cardioplegia are currently being used by our
team with promising preliminary results.   CT
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